| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lysine demethylase 6A | 0.498 | 0.769 | 1.00 |
|
disease | 0.520 | None | 1.000 | 2 | 0 | 2011 | 2018 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.500 | None | 1.000 | 26 | 0 | 2009 | 2019 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.390 | None | 1.000 | 9 | 0 | 1994 | 2019 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.370 | None | 1.000 | 7 | 0 | 2011 | 2018 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 1994 | 2007 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2012 | 2012 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.200 | None | 1.000 | 22 | 0 | 2009 | 2019 | ||||||||
|
serine and arginine rich splicing factor 2 | 0.561 | 0.731 | 0.48 |
|
disease | 0.200 | None | 1.000 | 10 | 0 | 2012 | 2018 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.130 | None | 1.000 | 3 | 4 | 2002 | 2017 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 1990 | 2014 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.100 | None | 1.000 | 10 | 1 | 2005 | 2019 | ||||||||
|
SET binding protein 1 | 0.503 | 0.808 | 1.00 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2013 | 2019 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2008 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.060 | None | 1.000 | 6 | 1 | 2006 | 2017 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 1994 | 2019 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2006 | 2019 | ||||||||
|
huntingtin interacting protein 1 | 0.653 | 0.577 | 0.76 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1998 | 2003 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2017 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2018 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 1987 | 2016 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1998 | 2017 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.050 | None | 1.000 | 4 | 0 | 1997 | 2017 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2012 | 2018 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 1989 | 2013 | ||||||||
|
U2 small nuclear RNA auxiliary factor 1 | 0.604 | 0.577 | 0.99 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 2013 | 2013 |